Details for 2022724683

Up to date per 01.04.2026

Actions

Title / Product Name

ANTI-IFNAR1-DOSIERUNGSSCHEMA ZUR SUBKUTANEN INJEKTION

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2022724683

EP Publication Number

4114465

E-Number

1604564

Language

PCT Number

EP22060592

Publication Date

11.01.2023 A

30.08.2023 B1

Registration Date

30.08.2023

AT Publication Date

15.09.2023

Application Date

21.04.2022

Registration Number

Priorities

23.04.2021

202163178739 P

17.09.2021

202163245285 P

28.10.2021

202163272851 P

IPC

A61K 39/395 20060101AFI20221007BHEP

Maximum Duration of Protection

21.04.2042

Owner

AstraZeneca AB 151 85 SödertäljeSE

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

LINDHOLM, Catharina SE-151 85 SödertäljeSE

CHIA, Yen Lin Wilmington, Delaware 19850-5437US

TUMMALA, Rajendra Wilmington, Delaware 19850-5437US

ROSKOS, Lorin Gaithersburg, Maryland 20878US

ALMQUIST, Joachim SE-151 85 SödertäljeSE

ROUSE, Tomas SE-151 85 SödertäljeSE

Information about Fees